This is the subject of a 60-min webinar on 23rd January 2019.
There has been an "explosion” of interest in this area largely due to the success of chimeric antigen receptor (CAR) T-cell therapy. The fields of immunology and gene therapy have converged to harness recombinant viruses to deliver “living drugs” with remarkable clinical efficacy, especially for patients with blood cancers. Multiple approaches to engineer immune cells—mostly T cells but also other immune cell types—make use of CARs, while tumor-specific T-cell receptors continue to gain a foothold in the field, mostly for the treatment of solid tumors
During the webinar, the speakers will:
Outline the current state of cell therapy and gene therapy for #cancer
Share their experience with the challenges of applying these therapies in a practical way
Speculate on possible future directions and applications for cell and gene therapy, including adoptive immunotherapy safety and efficacy, and advances in T-cell bioengineering methodologies
More details and registration available through this site: https://www.sciencemag.org/custom-publishing/webinars/cell-and-gene-therapies-cancer-future-promises-and-challenges